1. Home
  2. ACRS vs GTN Comparison

ACRS vs GTN Comparison

Compare ACRS & GTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.77

Market Cap

529.9M

Sector

Health Care

ML Signal

HOLD

GTN

Gray Television Inc.

HOLD

Current Price

$4.61

Market Cap

432.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
GTN
Founded
2012
1897
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
529.9M
432.5M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
ACRS
GTN
Price
$3.77
$4.61
Analyst Decision
Strong Buy
Buy
Analyst Count
12
5
Target Price
★ $10.18
$6.50
AVG Volume (30 Days)
★ 3.5M
829.9K
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
★ 6.81%
EPS Growth
★ 69.01
N/A
EPS
N/A
★ N/A
Revenue
$1,683,000.00
★ $3,095,000,000.00
Revenue This Year
N/A
$17.38
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.10
$3.55
52 Week High
$6.60
$6.44

Technical Indicators

Market Signals
Indicator
ACRS
GTN
Relative Strength Index (RSI) 39.97 50.33
Support Level $3.18 $4.47
Resistance Level $3.86 $4.70
Average True Range (ATR) 0.31 0.18
MACD 0.07 0.02
Stochastic Oscillator 54.05 52.63

Price Performance

Historical Comparison
ACRS
GTN

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform. The company's pipeline consists of the following key product candidates: Bosakitug (ATI-045), an investigational, novel, humanized anti-TSLP monoclonal antibody being developed for patients with severe asthma, COPD, and chronic rhinosinusitis with nasal polyps; ATI-2138, being developed for the potential treatment of T cell-mediated autoimmune diseases; and ATI-052 and ATI-9494. Additionally, it has an investigational product candidate, Lepzacitinib (ATI-1777), which is being focused upon as a potential treatment for atopic dermatitis and potentially other dermatologic conditions.

About GTN Gray Television Inc.

Gray Media Inc is a multimedia company. The company owns and operates local television stations and digital assets. It also owns Gray Digital Media, a full-service digital agency offering national and local clients digital marketing strategies with digital products and services. Its additional media properties include video production companies Raycom Sports, Tupelo Media Group, and PowerNation Studios, and studio production facilities Assembly Atlanta and Third Rail Studios. The company's segments include Broadcasting and Production Companies. The majority of revenue is derived from broadcast and digital advertising and from retransmission consent fees.

Share on Social Networks: